Mar 12, 2019 / 12:40PM GMT
Doug Schenkel - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
All right. Good morning, everyone. I'm a Doug Schenkel, one of the health care analysts here at Cowen. Welcome to our presentation and fireside chat with Hologic. Up on stage with us, we have Karleen Oberton, who is Hologic's Chief Financial Officer; and Mike Watts, Vice President of Investor Relations.
Just to give you a roadmap for the next half hour, Karleen's going to run through some prepared remarks for the next 10, 15 minutes, something like that; then we'll transition into our traditional fireside chat format. Really, we're going to focus a lot on Hologic's key growth drivers, if time permits, in this session. We'll then dig into some of the margin expansion story and capital deployment priorities. Whatever we don't get through here, we can cover in our breakout session in the Nantucket Room, which is right around the corner on the fourth floor.
So thanks for being here. With that, let me hand it off to Karleen and -- okay, go ahead.
Karleen M. Oberton -
Hologic Inc at Cowen Health Care Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
